Position history for GOLDMAN SACHS GROUP INC's holdings in TAYSHA GENE THERAPIES INC
GOLDMAN SACHS GROUP INC holds 22.4M shares of TSHA (TAYSHA GENE THERAPIES INC), worth $100M as of 2026-Q1. The position was increased (+63.4% shares). TSHA represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.
Current Value
$100M
Current Shares
22.4M
Total Value Change
+$98.3M
Total Shares Change
+21.4M
Other major holders of TSHA: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, BlackRock, Inc.
Increased |
| 22.4M |
+63.4% |
| $100M |
| 0.0% |
| $4.53 |
44 |
| 2025-Q4 | Increased | 13.7M | +2.3% | $75.3M | 0.0% | $5.66 | 30 |
| 2025-Q3 | Increased | 13.4M | +6.3% | $43.8M | 0.0% | $3.16 | 31 |
| 2025-Q2 | Increased | 12.6M | +3406.3% | $29.1M | 0.0% | $2.38 | 46 |
| 2025-Q1 | Decreased | 359,007 | -62.9% | $499,019 | 0.0% | $1.93 | 0 |
| 2024-Q4 | New | 967,144 | - | $1.7M | 0.0% | $1.73 | 36 |